Gabapentin is not appreciably metabolized in humans 16,17 - in humans, metabolites account for less than 1% of an administered dose, with the remainder being
Gabapentin is not appreciably metabolized in humans. Gabapentin elimination half-life is 5 to 7 hours and is unaltered by dose or following multiple dosing.
Gabapentin is not appreciably metabolized in humans - in humans, metabolites account for less than 1% of an administered dose, with the remainder being excreted
Gabapentin is not appreciably metabolized in humans. Gabapentin elimination half-life is 5 to 7 hours and is unaltered by dose or following multiple dosing.
Gabapentin is not appreciably metabolized in humans. Gabapentin elimination half-life is 5 to 7 hours and is unaltered by dose or following multiple dosing.
High doses of gabapentin can result in adverse effects in humans. Acute renal failure, exacerbation of chronic renal failure, and hepatotoxicity have been reported in human patients taking gabapentin. In cats, dogs, and humans, gabapentin has been found to cause sedation ataxia, and dizziness (in human patients) In a previous
Gabapentin is not appreciably metabolized in humans. Gabapentin elimination half-life is 5 to 7 hours and is unaltered by dose or following multiple dosing
Pregnancy. Gabapentin crosses the human placenta. Congenital These doses are approximately 1 to 5 times the human dose of 3600 mg
High doses of gabapentin can result in adverse effects in humans. Acute renal failure, exacerbation of chronic renal failure, and hepatotoxicity have been reported in human patients taking gabapentin. In cats, dogs, and humans, gabapentin has been found to cause sedation ataxia, and dizziness (in human patients) In a previous
Comments
Bravo! A very refreshing interpretation, with a good dose of the human condition prevalent well done!